Annual long term liabilities:
$222.17M-$15.80M(-6.64%)Summary
- As of today (June 29, 2025), CRSP annual total long term liabilities is $222.17 million, with the most recent change of -$15.80 million (-6.64%) on December 31, 2024.
- During the last 3 years, CRSP annual long term liabilities has fallen by -$10.36 million (-4.46%).
- CRSP annual long term liabilities is now -9.86% below its all-time high of $246.47 million, reached on December 31, 2022.
Performance
CRSP Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$217.50M-$4.68M(-2.11%)Summary
- As of today (June 29, 2025), CRSP quarterly total long term liabilities is $217.50 million, with the most recent change of -$4.68 million (-2.11%) on March 31, 2025.
- Over the past year, CRSP quarterly long term liabilities has dropped by -$18.60 million (-7.88%).
- CRSP quarterly long term liabilities is now -17.33% below its all-time high of $263.09 million, reached on September 30, 2016.
Performance
CRSP quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CRSP Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.6% | -7.9% |
| 3 y3 years | -4.5% | -12.2% |
| 5 y5 years | +216.4% | +228.9% |
CRSP Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.9% | at low | -13.9% | at low |
| 5 y | 5-year | -9.9% | +219.8% | -13.9% | +277.8% |
| alltime | all time | -9.9% | +3396.0% | -17.3% | +344.5% |
CRSP Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $217.50M(-2.1%) |
| Dec 2024 | $222.17M(-6.6%) | $222.17M(-2.0%) |
| Sep 2024 | - | $226.66M(-1.9%) |
| Jun 2024 | - | $231.08M(-2.1%) |
| Mar 2024 | - | $236.09M(-0.8%) |
| Dec 2023 | $237.98M(-3.4%) | $237.98M(-4.0%) |
| Sep 2023 | - | $247.80M(-0.1%) |
| Jun 2023 | - | $248.15M(+2.3%) |
| Mar 2023 | - | $242.67M(-1.5%) |
| Dec 2022 | $246.47M(+6.0%) | $246.47M(-0.8%) |
| Sep 2022 | - | $248.53M(-1.6%) |
| Jun 2022 | - | $252.57M(+2.0%) |
| Mar 2022 | - | $247.56M(+6.5%) |
| Dec 2021 | $232.53M(+234.7%) | $232.53M(+9.4%) |
| Sep 2021 | - | $212.60M(+8.6%) |
| Jun 2021 | - | $195.80M(+182.5%) |
| Mar 2021 | - | $69.32M(-0.2%) |
| Dec 2020 | $69.47M | $69.47M(+20.7%) |
| Sep 2020 | - | $57.57M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $61.36M(-7.2%) |
| Mar 2020 | - | $66.12M(-5.8%) |
| Dec 2019 | $70.22M(+1.7%) | $70.22M(+43.5%) |
| Sep 2019 | - | $48.93M(-48.6%) |
| Jun 2019 | - | $95.15M(+6.1%) |
| Mar 2019 | - | $89.67M(+29.8%) |
| Dec 2018 | $69.08M(+0.1%) | $69.08M(-0.3%) |
| Sep 2018 | - | $69.31M(-0.3%) |
| Jun 2018 | - | $69.50M(-0.3%) |
| Mar 2018 | - | $69.72M(+1.0%) |
| Dec 2017 | $69.00M(-23.4%) | $69.00M(-24.4%) |
| Sep 2017 | - | $91.24M(-0.1%) |
| Jun 2017 | - | $91.36M(+1.2%) |
| Mar 2017 | - | $90.26M(+0.2%) |
| Dec 2016 | $90.12M(-49.5%) | $90.12M(-65.7%) |
| Sep 2016 | - | $263.09M(+241.1%) |
| Jun 2016 | - | $77.12M(-56.8%) |
| Dec 2015 | $178.39M(+2707.1%) | $178.39M |
| Dec 2014 | $6.36M | - |
FAQ
- What is CRISPR Therapeutics AG annual total long term liabilities?
- What is the all time high annual long term liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual long term liabilities year-on-year change?
- What is CRISPR Therapeutics AG quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly long term liabilities year-on-year change?
What is CRISPR Therapeutics AG annual total long term liabilities?
The current annual long term liabilities of CRSP is $222.17M
What is the all time high annual long term liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total long term liabilities is $246.47M
What is CRISPR Therapeutics AG annual long term liabilities year-on-year change?
Over the past year, CRSP annual total long term liabilities has changed by -$15.80M (-6.64%)
What is CRISPR Therapeutics AG quarterly total long term liabilities?
The current quarterly long term liabilities of CRSP is $217.50M
What is the all time high quarterly long term liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total long term liabilities is $263.09M
What is CRISPR Therapeutics AG quarterly long term liabilities year-on-year change?
Over the past year, CRSP quarterly total long term liabilities has changed by -$18.60M (-7.88%)